PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Dicyclohexyl phthalate

EC / List no: 201-545-9 CAS no: 84-61-7
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Ongoing
Decision date
Decision
Latest update
18-Aug-2022
Additional information
More information View
DEv 2
Scope
Comprehensive
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Sweden
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Year
2017
Status
Follow-up
Conclusion document
Latest update
13-Nov-2020
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Sweden
Status
Under development under SEV
Outcome
Under development (SEV)
Hazard assessment outcome document
Remarks
The substance is now under SEv to clarify the concern related to the potential for environmental endocrine disruption.

The substance has been identified as SVHC due to its ED HH properties.

The SHVC proposal for ED Env was withdrawn because the existing data concerning potential endocrine disrupting effects was considered not sufficient to conclude/agree that DCHP has endocrine disrupting properties for which there is evidence of probable serious adverse effects to the environment giving rise to equivalent level of concern.
Concern
Endocrine disruption
Date of intention
14-Sep-2020
Date of hazard assessment
Latest update
03-Feb-2021
More information View
ED 2
Authority
Sweden
Status
Concluded
Outcome
ED HH
Hazard assessment outcome document
Remarks
Identified as SVHC in accordance with Article 57(f) of REACH due to its endocrine disrupting properties with probable serious effects to human health and in accordance with Article 57(c) of REACH due to its harmonised classification as toxic for reproduction category 1B under CLP.
Concern
Endocrine disruption
Date of intention
20-Mar-2015
Date of hazard assessment
27-Jun-2018
Latest update
03-Feb-2021
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Opinion Adopted
Date of intention
12-Feb-2013
Withdrawal date
Submitter
Sweden
Proposed harmonised classification by the dossier submitter
Skin Sens. 1, H317
Repr. 1B, H360FD
Remarks
Date of opinion
04-Dec-2014
RAC Opinion
Latest update
02-Apr-2019
More information View
SVHC - Substances of very high concern
SVHC 1
Status
Identified SVHC
Date of intention
20-Mar-2015
Withdrawal date
Submitter
Sweden
Remarks
Scope
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
Date of inclusion in Candidate List
27-Jun-2018
Latest update
07-Dec-2021
More information View
Recom - Recommendations for inclusion in the Authorisation List
Recom 1
Intrinsic property
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
Status
Recommended for inclusion in Annex XIV
Recommendation round
10th recommendation
Date of draft recommendation
05-Mar-2020
Date of final recommendation
14-Apr-2021
Final recommendation
Date of inclusion in Authorisation List
Regulation amending Annex XIV
Remarks
More information View
Assessment of regulatory needs
ARN 1
Authority
ECHA
Concern
Status
Under development
Follow-up
CCH
Foreseen regulatory need
Annex XIV
Restriction
Summary document
Group name
Ortho-phthalates
Remarks
Date of intention
01-Mar-2020
Date of assessment
21-Jun-2021
Latest update
07-Dec-2021
More information View
ARN 2
Authority
Sweden
Concern
Endocrine disruption
Status
Concluded
Follow-up
SVHC
Foreseen regulatory need
Summary document
Group name
Remarks
Date of intention
20-Mar-2015
Date of assessment
07-Sep-2015
Latest update
24-Nov-2021
More information View

List entry date: 21-Mar-2017

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.